Skip to main content

MoneyWorks4Me

The revenue zoomed 18.03% to Rs. 1026.97 millions for the quarter ended December 2024 as compared to Rs. 870.08 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended December 2024 rise to 26.34% to Rs. 53.33  millions  compared to R. 42.21 millions in corresponding previous quarter.Operating profit for the quarter ended December 2024 rose to 132.29 millions as compared to 105.15 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1026.97 870.08 18.03 2888.62 2310.38 25.03 3490.72 2764.98 26.25
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 132.29 105.15 25.81 376.60 277.30 35.81 388.98 296.00 31.41
Interest 50.05 37.66 32.90 142.29 92.78 53.36 136.50 92.82 47.06
PBDT 82.24 67.49 21.86 234.31 184.52 26.98 252.48 203.18 24.26
Depreciation 10.89 9.86 10.45 31.99 28.40 12.64 37.96 28.09 35.14
PBT 71.35 57.63 23.81 202.32 156.12 29.59 214.52 175.09 22.52
TAX 18.02 15.42 16.86 64.94 50.52 28.54 58.28 67.02 -13.04
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 53.33 42.21 26.34 137.38 105.60 30.09 156.24 108.07 44.57
Equity 47.22 46.99 0.49 47.22 46.99 0.49 46.99 45.32 3.68
PBIDTM(%) 12.88 12.09 6.59 13.04 12.00 8.62 11.14 10.71 4.09
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..